TYP 0.00% 4.9¢ tryptamine therapeutics limited

Ann: Exopharm Gains US Patent for LEAP Technology, page-4

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 2,966 Posts.
    lightbulb Created with Sketch. 71
    What did BB say that isn’t true? He’s not down ramping or starting an argument. He’s speaking the truth as a shareholder.

    Ex1 has been a massive disappointment in terms of shareprice since the second last capital raise. They over promised and have under delivered. If you look at the shareprice chart and think it hasn’t been a disappointment then we’re on different planets.

    They need to do what they said they were close to a long time ago, land a deal.
 
watchlist Created with Sketch. Add TYP (ASX) to my watchlist
(20min delay)
Last
4.9¢
Change
0.000(0.00%)
Mkt cap ! $60.10M
Open High Low Value Volume
5.0¢ 5.1¢ 4.6¢ $297.0K 6.063M

Buyers (Bids)

No. Vol. Price($)
1 12000 4.8¢
 

Sellers (Offers)

Price($) Vol. No.
4.9¢ 249224 2
View Market Depth
Last trade - 16.10pm 15/11/2024 (20 minute delay) ?
TYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.